• Clinical Trials
  • Education
  • Financial
  • Mental Health
  • Press
  • Research/Report
  • Support

  • AMA
  • American Association for Cancer Research
  • American Cancer Society
  • ASCO
  • Asian Women for Health
  • BioSpace
  • Boston Globe
  • Boston Public Health Commission
  • Bristol Myers Squibb
  • CNN Health
  • Dana-Farber Cancer Institute
  • Expect Miracles Foundation
  • Family Reach
  • Gryt Health
  • Harvard Cancer Center
  • Harvard School of Public Health
  • Latinas In Medicine
  • Leukemia Lymphoma Society
  • Mental Health Liberation
  • NAMI
  • National Alliance for Caregiving
  • National Asian American Pacific Islander Mental Health Association
  • National Institutes of Health
  • PAN CAN
  • PhRMA
  • Syenos Health
  • Syneos Health
  • The New England Journal of Medicine
  • Tufts University

Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery

October 20, 2022

Cancer prevention and treatment systems are significantly impacted by interpersonal, organizational, and structural and systemic racism. A wide body of research has found that racial disparities in access to guideline-adherent cancer care are pervasive throughout the United States and contributing factors include social determinants of health, insurance status, and bias and discrimination in care delivery.

New Federal Incentives for Diversity in Clinical Trials

October 13, 2022

"In June 2022, the U.S. House of Representatives passed legislation intended to increase the diversity of the populations enrolled in clinical trials of new drugs. Under this bill, study sponsors would be required to submit a diversity action plan — including goals for study enrollment according to demographic group and steps for achieving those goals — for phase 3 or pivotal studies of new drugs."

New Study Shows Cancer Mortality Higher Among American Indian and Alaska Native Individuals; Colorectal Cancer Rapidly Increasing Before Age 50

November 8, 2022

Researchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals.

Health Equity Chart Pack

Equitable access to quality medicines and care will meaningfully transform the lives of millions of Americans - particularly those in our most vulnerable and underserved communities.

Predicting Risks and Benefits for Lung Cancer Screening

November 16, 2022

IRP Researchers Refine Tools to Maximize the Benefit from Life-Saving Tests

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

October 29, 2020

While cancer screening is integral to cancer control and prevention, due to the COVID-19 outbreak many screenings have either been canceled or postponed, leaving a vast number of patients without access to recommended health care services.

US Residents of Mexican Descent May Have a Higher Risk of Liver Cancer With Each Successive Generation

September 16, 2022

"Second- and third-generation individuals living in Los Angeles had a 35 and 61 percent higher risk, respectively, than those born in Mexico"

US lung cancer survival rate rises 21%, report says, but much work remains

November 15, 2022

The five-year lung cancer survival rate has increased 21%, from 21% in 2014 to 25% in 2018, making what experts call “remarkable progress” – but it is still the leading cause of cancer death in the United States.

Expect Miracles Foundation's Samfund

Samfund provides critical resources to young adult cancer survivors. Young adults are a vulnerable and underserved segment of the cancer community. It helps young adults who are struggling with expenses through two grant categories: Financial Assistance Grants and Family Building Grants.

Mental Health Liberation: BIPOC Therapy Fund

Since 2019, Mental Health Liberation's Inclusive Therapists community has prioritized mental health care access for Black, Indigenous and People of Color (BI&POC).

Dana-Farber Cancer Institute: Free Flight Resources

Free flight resources available to patients and families at Dana-Farber.

Dana-Farber/Harvard Cancer Center: Patient Navigation Network

The Patient Navigator Network (PNN) was formed in 2007 to bring together oncology patient navigators across Dana-Farber/Harvard Cancer Center (DF/HCC) institutions and other institutions for training, networking and peer-to-peer support.

Page 1 of 7